» Articles » PMID: 8818561

Psychopharmacology for Dermatologic Patients

Overview
Journal Dermatol Clin
Specialty Dermatology
Date 1996 Jul 1
PMID 8818561
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

In the recent past, there has been great progress made in making psychopharmacologic agents both more efficacious and more user friendly. If dermatologists are to more effectively treat psychodermatologic patients who refuse to see a mental health professional, judicious and responsible use of psychopharmacology is still the most feasible way to treat many of these patients. This article illustrates the use of several commonly used psychopharmacologic agents. Even for psychiatrists, it is not realistic to try to master all psychopharmacologic agents that are on the market. Familiarity with the use of medications discussed in this article is likely to add significantly to the therapeutic armamentarium of a dermatologic practitioner.

Citing Articles

Fluoxetine for the treatment of onychotillomania associated with obsessive-compulsive disorder: a case report.

Aljhani S J Med Case Rep. 2022; 16(1):431.

PMID: 36403006 PMC: 9675954. DOI: 10.1186/s13256-022-03652-9.


Update on Diagnosis and Management of Onychophagia and Onychotillomania.

Lee D, Lipner S Int J Environ Res Public Health. 2022; 19(6).

PMID: 35329078 PMC: 8953487. DOI: 10.3390/ijerph19063392.